JP2023511184A5 - - Google Patents
Info
- Publication number
- JP2023511184A5 JP2023511184A5 JP2022544413A JP2022544413A JP2023511184A5 JP 2023511184 A5 JP2023511184 A5 JP 2023511184A5 JP 2022544413 A JP2022544413 A JP 2022544413A JP 2022544413 A JP2022544413 A JP 2022544413A JP 2023511184 A5 JP2023511184 A5 JP 2023511184A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- val
- cit
- gly
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062964181P | 2020-01-22 | 2020-01-22 | |
| US62/964,181 | 2020-01-22 | ||
| PCT/EP2021/051259 WO2021148500A1 (en) | 2020-01-22 | 2021-01-21 | Compounds and conjugates thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023511184A JP2023511184A (ja) | 2023-03-16 |
| JP2023511184A5 true JP2023511184A5 (cg-RX-API-DMAC7.html) | 2024-01-30 |
Family
ID=74494865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544413A Pending JP2023511184A (ja) | 2020-01-22 | 2021-01-21 | 化合物及びその複合体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230097908A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4093439A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023511184A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220130749A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114980934A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021210570A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022014391A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3166732A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022009052A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021148500A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118414339A (zh) * | 2021-12-16 | 2024-07-30 | 迈威(上海)生物科技股份有限公司 | 一种喜树碱类化合物及其偶联物 |
| AU2023279443A1 (en) | 2022-06-03 | 2025-01-23 | Ube Corporation | Antibody-multidrug conjugate |
| CN115160403B (zh) * | 2022-07-05 | 2025-06-27 | 博石丰生命科技(南通)有限公司 | 特异性拓扑异构酶抑制剂和可用于抗体药物偶联物及其制备方法 |
| WO2026078165A1 (en) | 2024-10-10 | 2026-04-16 | Astrazeneca Ab | Conjugates comprising cleavable linkers |
| WO2026145631A1 (zh) * | 2024-12-31 | 2026-07-09 | 上海复宏汉霖生物技术股份有限公司 | 一种配体-药物偶联物及制备方法和应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
| JP2540357B2 (ja) * | 1987-06-24 | 1996-10-02 | 第一製薬株式会社 | 六環性化合物 |
| JP3008226B2 (ja) * | 1991-01-16 | 2000-02-14 | 第一製薬株式会社 | 六環性化合物 |
| TR201808537T4 (tr) | 2004-09-23 | 2018-07-23 | Genentech Inc | Sistein değiştirilmiş antikorlar ve konjugatlar. |
| NZ567140A (en) | 2005-10-07 | 2011-09-30 | Exelixis Inc | Azetidines as MEK inhibitors for the treatment of proliferative diseases |
| DK1813614T3 (da) | 2006-01-25 | 2012-01-23 | Sanofi Sa | Cytotoksiske midler, der omfatter nye tomaymycinderivater |
| JP5394246B2 (ja) * | 2007-03-30 | 2014-01-22 | ジェネンテック, インコーポレイテッド | 抗体及びイムノコンジュゲートとこれらの使用方法 |
| PE20090245A1 (es) | 2007-05-08 | 2009-03-17 | Genentech Inc | Anticuerpos anti-muc16 disenados con cisteina y conjugados de anticuerpos y farmacos |
| BRPI0818780A2 (pt) | 2007-10-19 | 2015-04-22 | Genentech Inc | Anticorpo anti-tenb2 planejados por cisteína e conjugados de medicamento com anticorpos |
| EA201200486A1 (ru) * | 2009-09-15 | 2012-08-30 | Серулин Фарма Инк. | Лечение онкологических заболеваний |
| TWI871999B (zh) * | 2014-04-10 | 2025-02-01 | 日商第一三共股份有限公司 | 抗her3抗體-藥物結合物 |
| HUE067016T2 (hu) * | 2015-11-25 | 2024-09-28 | Ligachem Biosciences Inc | Önfeláldozó csoportokat tartalmazó konjugátumok és ezekkel kapcsolos eljárások |
| GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| US20190367605A1 (en) | 2016-11-10 | 2019-12-05 | Medimmune, Llc | Binding Molecules Specific For ASCT2 And Uses Thereof |
| JP7244987B2 (ja) * | 2016-12-14 | 2023-03-23 | シージェン インコーポレイテッド | 多剤抗体薬物コンジュゲート |
| KR20200142525A (ko) * | 2018-04-05 | 2020-12-22 | 노파르티스 아게 | 암에 대한 삼중특이성 결합 분자 및 이의 용도 |
| EP3794042B1 (en) * | 2018-05-18 | 2024-03-27 | Daiichi Sankyo Co., Ltd. | Anti-muc1- exatecan antibody-drug conjugate |
| KR20240104214A (ko) * | 2019-03-29 | 2024-07-04 | 메디뮨 리미티드 | 화합물 및 이의 접합체 |
| CN110974975B (zh) * | 2019-12-12 | 2023-10-20 | 成都百利多特生物药业有限责任公司 | 一种快速释放的抗体药物偶联物 |
| US12605459B2 (en) * | 2020-07-13 | 2026-04-21 | Regeneron Pharmaceuticals, Inc. | Protein-drug conjugates comprising camptothecin analogs and methods of use thereof |
| NL2026947B1 (en) * | 2020-11-20 | 2022-07-01 | Synaffix Bv | Tyrosine-based antibody conjugates |
-
2021
- 2021-01-21 US US17/759,083 patent/US20230097908A1/en not_active Abandoned
- 2021-01-21 EP EP21702596.4A patent/EP4093439A1/en not_active Withdrawn
- 2021-01-21 CA CA3166732A patent/CA3166732A1/en active Pending
- 2021-01-21 BR BR112022014391A patent/BR112022014391A2/pt not_active IP Right Cessation
- 2021-01-21 MX MX2022009052A patent/MX2022009052A/es unknown
- 2021-01-21 CN CN202180010092.XA patent/CN114980934A/zh active Pending
- 2021-01-21 KR KR1020227028552A patent/KR20220130749A/ko active Pending
- 2021-01-21 AU AU2021210570A patent/AU2021210570A1/en not_active Abandoned
- 2021-01-21 WO PCT/EP2021/051259 patent/WO2021148500A1/en not_active Ceased
- 2021-01-21 JP JP2022544413A patent/JP2023511184A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6937090B2 (ja) | 免疫調節剤としての1,2,4−オキサジアゾールおよびチアジアゾール化合物 | |
| CN108164474B (zh) | 作为免疫调节剂的1,2,4-二唑衍生物 | |
| JP2022528851A5 (cg-RX-API-DMAC7.html) | ||
| JP2023512501A5 (cg-RX-API-DMAC7.html) | ||
| JP2023018157A (ja) | 親水性抗体-薬物コンジュゲート | |
| US9096642B2 (en) | Therapeutic compounds for immunomodulation | |
| CN1113066C (zh) | 新型肽衍生物 | |
| JP3970317B2 (ja) | 酵素インヒビター | |
| AU2018271235A1 (en) | Cyclic peptidomimetic compounds as immunomodulators | |
| KR20170123680A (ko) | 면역조절제로서의 1,3,4-옥사다이아졸 및 티아다이아졸 화합물 | |
| KR20170125931A (ko) | 면역조절제로서의 3-치환된 1,3,4-옥사다이아졸 및 티아다이아졸 화합물 | |
| DE69223266T2 (de) | Peptidderivate und deren Verwendung | |
| HUE035463T2 (hu) | Citotoxikus peptidek és ezek antitest-hatóanyag konjugátumai | |
| KR20160081898A (ko) | 면역조절제로서 1,3,4-옥사디아졸 및 1,3,4-티아디아졸 유도체 | |
| CN107849090A (zh) | 抗体药物偶联物 | |
| WO2025040047A1 (zh) | 抗体偶联药物、其制备方法及应用 | |
| AU744425B2 (en) | 20(s) camptothecin glycoconjugates | |
| JP2020189806A (ja) | 複合体 | |
| JP5393482B2 (ja) | 抗癌活性を有するテトラサイクリン・アントラキノン系化合物 | |
| JP2022519002A (ja) | 酸法による抗体薬物複合体中間体の調製方法及びその応用 | |
| CN101077885A (zh) | 新型抗肿瘤化合物 | |
| HUT75538A (en) | Oligopeptides derived from c-reactive protein fragments | |
| CN102875651B (zh) | 抗肿瘤靶向激活的多肽阿霉素、其制备方法和用途 | |
| CN101153053B (zh) | 骨生肽、其制备方法和其药物组合物与用途 | |
| BRPI0621664A2 (pt) | conjugado de interferon alfa com polietileno glicol |